Bruker Spatial Biology

What Bruker Spatial Biology does

Bruker Spatial Biology, a division of Bruker Corporation (NASDAQ: BRKR), provides spatial biology instruments, assays, software, and services for spatial transcriptomics, proteomics, and multiomics. The division was established in 2024 following Bruker's April 17, 2024 acquisition of NanoString Technologies out of Chapter 11, absorbing the CosMx Spatial Molecular Imager, GeoMx Digital Spatial Profiler, nCounter Analysis System, CellScape Precise Spatial Proteomics, and PaintScape Spatial 3D Genome+ instrument lines, supported by the AtoMx Spatial Informatics Platform and proprietary technologies such as EpicIF signal-removal chemistry. Operations are headquartered in Bothell, Washington, with Customer Experience Labs in Seattle and Amsterdam, and the division targets biopharma, academic research, and healthcare organizations worldwide with vertical segmentation by use case. Revenue is generated through a combination of capital instrument sales, recurring assay and reagent consumables tied to instrument utilization, software licensing via AtoMx SIP, CRO/laboratory services through Canopy Multiomics, and custom solutions (CosMx Custom RBS, Custom Protein Barcoding). The go-to-market blends enterprise field sales with regional authorized distributors (e.g., Premas Life Sciences in India), Technology Access Programs for pilot evaluation, and event-driven demand generation at conferences such as AGBT and AACR, with quote-based multi-year contract pricing rather than publicly disclosed list prices.

Name

Bruker Spatial Biology

Legal name

Bruker Spatial Biology, Inc.

Website

https://brukerspatialbiology.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Bruker Spatial Biology, a division of Bruker Corporation, provides instruments, assays, software, and services for spatial transcriptomics, proteomics, and multiomics. Formed in 2024 after acquiring NanoString Technologies, it serves biopharma, academic, and clinical research customers worldwide.

Ownership category

akta.pro rank

Product category

Spatial Biology Instruments and Assays

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Software Publishers (513210)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

akta.pro secondary industries

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Proteomics & Biomarker Analytical Testing (HLAGADAG), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

Keywords

• Spatial biology instruments
• Spatial transcriptomics
• Spatial proteomics
• Digital spatial profiling
• Multiomics assays

Headquarters

HQ city

Billerica

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Spatial Biology Instruments and Platforms: Sale of capital equipment including CosMx Spatial Molecular Imager, GeoMx Digital Spatial Profiler, nCounter Analysis System, and CellScape Precise Spatial Proteomics platforms. Instruments represent significant capital expenditures for research institutions and biopharma companies.
2. Assay and Reagent Consumables: Recurring revenue from sale of assay panels, reagents, and consumables including CosMx RNA and Protein Assays, GeoMx Panels, nCounter Panels, VistaPlex kits, and custom solutions. Consumption tied to instrument utilization and run frequency.
3. Software and Informatics Platform: AtoMx Spatial Informatics Platform provides data analysis capabilities. May include licensing or subscription components for software access and updates.
4. Laboratory and CRO Services: Canopy Multiomics Services and Technology Access Program (TAP) allow customers to outsource imaging and data analysis. Service model enables revenue from samples submitted by customers without instrument purchase.
5. Custom Solutions and Services: CosMx Custom RBS (RNA Barcoding Service) and Custom Protein Barcoding Service enable researchers to create customized panels for additional fees.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels7 records

Core offering

Bruker Spatial Biology manufactures and sells scientific instruments, assays, and informatics software for spatial transcriptomics, spatial proteomics, and multiomics research. The portfolio includes the CosMx Spatial Molecular Imager, GeoMx Digital Spatial Profiler, nCounter Analysis System, CellScape Precise Spatial Proteomics platform, PaintScape Spatial 3D Genome+ system, and the AtoMx Spatial Informatics Platform, supported by assay panels, reagent consumables, custom solutions, and laboratory/CRO services.

Product overview

Bruker Spatial Biology offers a unified portfolio of best-in-class spatial biology instruments, assays, and informatics platforms designed to work together to capture the full complexity of biology. The core instrument portfolio includes: CosMx Spatial Molecular Imager for high-sensitivity subcellular imaging of the whole transcriptome at single-cell resolution; GeoMx Digital Spatial Profiler for discovery multiomics at scale; nCounter Analysis System for rapid targeted RNA and bulk multiomic expression analysis; CellScape Precise Spatial Proteomics platform for quantitative spatial phenotyping using cyclic multiplexed immunofluorescence; and PaintScape Spatial 3D Genome+ platform for multiplexed direct visualization of 3D genome architecture. Supporting these instruments is the AtoMx Spatial Informatics Platform for data analysis and the CosMx Same-Cell Multiomics capability enabling measurement of >19,000 RNAs and 64+ proteins from the same cell. The portfolio is complemented by comprehensive assay panels (RNA, protein, custom solutions), validated VistaPlex multiplexing assay kits, EpicIF signal removal technology, Technology Access Programs, and CRO/laboratory services. This integrated ecosystem enables researchers to profile from cells to tissue structures across multiple biological layers for spatial breakthroughs in drug development, biomarker discovery, and precision medicine.

Differentiator

Problem solved

Functional benefit

Brands

• CosMx: Spatial Molecular Imager platform for single-cell and subcellular spatial transcriptomics and proteomics imaging
• GeoMx
• nCounter
• CellScape
• PaintScape
• AtoMx
• VistaPlex
• EpicIF
• NanoString University

Products and services

• CosMx Spatial Molecular Imager High-sensitivity, subcellular imaging platform for whole transcriptome spatial analysis at single-cell resolution, enabling complete pathway-level spatial insights from FFPE or fresh frozen tissue samples for research and drug development teams.
• GeoMx Digital Spatial Profiler Discovery multiomics platform for profiling cells and tissue structures at scale, enabling spatial biomarker discovery with high-plex RNA and protein profiling for translational and clinical research customers.
• nCounter Analysis System Rapid and robust targeted RNA and multiomic expression analysis system proven for translational through clinical studies, featuring the nCounter Pro and nCounter Sprint Profiler instruments for research and clinical research customers.
• CellScape Precise Spatial Proteomics Flexible subcellular proteomics platform for rapid and quantitative spatial phenotyping using cyclic multiplexed immunofluorescence with EpicIF signal removal technology, supporting up to 60+ markers in single automated runs for research and biopharma customers.
• PaintScape Spatial 3D Genome+ First and only high precision platform enabling multiplexed, direct visualization of the 3D genome in situ in single cells, allowing researchers to visualize chromosomal organization and investigate how spatial genome structural variations influence gene dysregulation.
• AtoMx Spatial Informatics Platform Informatics platform designed to accelerate study-level insights from CosMx SMI data, providing no-code analysis modules, data export capabilities (TileDB, Seurat, flat files), and 3D AI cell segmentation for accurate RNA transcript assignment.
• CosMx RNA and Protein Assays Off-the-shelf assay panels including Whole Transcriptome Panel (>19,000 RNAs), 1000-plex Universal Cell Characterization Panel, 6K Human Discovery Panel, and 64+ protein panels for CosMx SMI imaging, sold as consumables to instrument customers.
• VistaPlex Multiplexing Assay Kits Validated antibody panels for CellScape platform including Tissue Architecture Assay Kit, Spatial Immune Profiling Assay Kit, and Cell Boundaries Assay Kit for human FFPE tissue, designed for robust assay performance with modular flexibility.
• GeoMx Discovery Proteome Atlas Spatial assay profiling more than 1,200 protein targets, enabling large-cohort interrogation of the whole transcriptome combined with deep proteomics for spatial biomarker discovery at scale.
• Canopy Multiomics Services / Laboratory CRO Services Contract research organization services including Canopy Multiomics Services offering sample submission, automated staining, high-plex imaging, cell phenotyping, and outsourced data analysis for CellScape and other platforms.
• CosMx and GeoMx Custom Solutions CosMx Custom RBS (RNA Barcoding Service) and Custom Protein Barcoding Service plus GeoMx Custom Solutions enable researchers to create customized panels for additional fees beyond off-the-shelf assay content.
• Technology Access Program (TAP) Program enabling researchers to generate data using CosMx SMI, CellScape, and other Bruker platforms before committing to capital purchase, facilitating adoption through hands-on evaluation experiences.

Quantifiable outcome

• 7,000+ peer-reviewed publications enabled by Bruker Spatial Biology technologies
• +2 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature8 records

Partnerships

Four partnerships are on record, tiered core and supporting.

• Noetik Inc.coreStrategic or Co-development Partner · 24 February 2026Expanded collaboration to advance spatial biology and AI foundation models for therapeutic applications in oncology. Partnership involves imaging thousands of additional patient samples using CosMx SMI to train Noetik's AI models toward a goal of one billion spatially resolved human cells. Noetik's virtual cell models simulate patient biology to inform drug discovery, representing advancement in precision oncology through AI-powered tissue analysis.
• Premas Life SciencescoreChannel Partner/ Reseller/ Distributor · 12 February 2026Appointed as authorized distributor for Bruker Spatial Biology in India, enabling expanded access to advanced spatial biology technologies including CosMx Spatial Molecular Imager, GeoMx Digital Spatial Profiler, and CellScape platform for Indian researchers and healthcare institutions. Partnership leverages Premas Life Sciences' nearly two decades of local expertise and nationwide presence to support Bruker's spatial biology portfolio as a strategic growth engine. Collaboration aims to strengthen biomedical research infrastructure, advance precision medicine capabilities, and support India's national priorities in translational science and healthcare innovation.
• Proteintech GroupsupportingTechnology or IntegrationCollaboration to develop VistaFlex universal antibody labeling capability, enabling use of virtually any IHC-validated unlabeled antibody on the CellScape platform without need for antibody stripping. VistaFlex broadens assay design freedom and opens access to wider range of protein targets and application-specific antibodies.
• Human Cell Atlas ProjectsupportingStrategic or Co-development PartnerResearch partnership where CosMx SMI complemented efforts to generate organ atlases of the healthy human system. CosMx SMI allowed visualization of single-cell reference maps directly in organs using 1000-plex gene panel with image-guided cell segmentation.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Illumina: Broader life-science tools incumbent whose sequencing platforms underpin adjacent spatial workflows (e.g., Visium) and whose AGBT-stage competitive claims against CosMx position it as an indirect competitor across the spatial transcriptomics stack.
• Bio-Techne: Diversified life-science tools provider offering RNAscope in situ hybridization and protein reagents that overlap with Bruker Spatial Biology's spatial transcriptomics and proteomics workflows, often appearing in the same customer purchase decisions.

Direct peers

• Vizgen: Direct competitor in single-cell spatial transcriptomics with its MERFISH technology platform, offering subcellular-resolution RNA imaging that overlaps with CosMx SMI's target use cases in cell biology and oncology.
• Akoya Biosciences: Competes directly with CellScape in spatial proteomics via the PhenoCycler-Fusion (formerly CODEX) and OPAL multiplexed immunofluorescence workflows, targeting the same translational research and immuno-oncology customers.
• Resolve Biosciences: Spatial transcriptomics competitor using Molecular Cartography technology to deliver subcellular-resolution RNA imaging, positioned as a direct alternative to CosMx SMI for researchers requiring single-molecule sensitivity.
• 10x Genomics: Direct competitor across spatial transcriptomics (Xenium vs. CosMx SMI) and spatial discovery (Visium HD vs. GeoMx DSP). 10x is the most direct head-to-head rival and was the patent litigant in the recent UPC disputes.
• Standard BioTools: Formerly Fluidigm; competes with Bruker Spatial Biology across multiplexed spatial and single-cell workflows, including imaging mass cytometry and targeted transcriptomics, serving similar translational and academic accounts.

Emerging players

• Rebus Biosystems: Emerging spatial-omics player with the Tempest platform targeting high-throughput, low-cost spatial transcriptomics. Represents a potential fit-for-purpose challenger to CosMx in routine biomarker applications.

Others

• Leica Microsystems: Microscopy and imaging instrument provider (Danaher subsidiary) whose high-end imaging platforms underpin many spatial-biology workflows. Functions as an adjacent enabler rather than a direct competitor, but is increasingly bundled with spatial analysis offerings.
• Hamamatsu Photonics: Supplier of high-sensitivity cameras, detectors, and imaging components used across spatial-biology instruments including CosMx SMI and CellScape. Operates as an enabling infrastructure provider in the spatial-biology ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/brukerspatial
• YouTubeyoutube.com/@brukerspatial
• Facebookfacebook.com/BrukerSpatial
• LinkedInlinkedin.com/company/bruker-spatial
• Instagraminstagram.com/BrukerSpatial

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bruker Spatial Biology